Anika Therapeutics
ANIK
ANIK
117 hedge funds and large institutions have $311M invested in Anika Therapeutics in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
1% more funds holding
Funds holding: 116 → 117 (+1)
23% less call options, than puts
Call options by funds: $61K | Put options by funds: $79K
Holders
117
Holding in Top 10
3
Calls
$61K
Puts
$79K
Top Buyers
| 1 | +$16.4M | |
| 2 | +$6.15M | |
| 3 | +$4.36M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.91M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$2.64M |
Top Sellers
| 1 | -$5.67M | |
| 2 | -$5.59M | |
| 3 | -$2.75M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$2.45M |
| 5 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$1.77M |